Danaparoid (Orgaran)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 04:23, 5 June 2023 by Jwarner (talk | contribs) (→‎History of changes in FDA indication)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

General information

Class/mechanism: Low molecular weight heparin

History of changes in FDA indication

  • 2001-06-26: Initial approval

Also known as

  • Brand name: Orgaran
Retrieved from "https://hemonc.org/w/index.php?title=Danaparoid_(Orgaran)&oldid=72210"